echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A&R: Variations in UBE2L3/YDJC autoimmune disease risk haplotypes increase UBE2L3 expression by modulating CCCTC-binding factor and YY1 binding

    A&R: Variations in UBE2L3/YDJC autoimmune disease risk haplotypes increase UBE2L3 expression by modulating CCCTC-binding factor and YY1 binding

    • Last Update: 2022-02-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Objective: Genetic variants spanning UBE2L3 are associated with increased expression of UBE2L3 - encoded E2 ubiquitin-conjugating enzyme H7 (UbcH7) , which contributes to activation of pro-inflammatory NF-κB signaling and increased susceptibility to autoimmune disease .
    We conducted this study to describe how genetic variation drives hypermorphic UBE2L3 expression (hypermorphic expression: increased levels of gene product activity, or increased horizontal expression of wild-type gene products) through UBE2L3/YDJC autoimmune risk haplotype function.
    .
    )

    Objective: Genetic variation across UBE2L3 UBE2L3 is associated with increased expression of UBE2L3 - encoded E2 ubiquitin-conjugating enzyme H7 (UbcH7) , which contributes to activation of pro-inflammatory NF-κB signaling and increased susceptibility to autoimmune disease .


    We conducted this study to describe how genetic variation drives hypermorphic UBE2L3 UBE2L3 expression (hypermorphic expression: increased levels of gene product activity, or wild-type gene product) through UBE2L3/YDJC UBE2L3/YDJC autoimmune risk haplotype function.
    increased expression .


    Methods: We used bioinformatics analysis, electrophoretic mobility shift assay ( EMSA ), and luciferase reporter gene assays to identify and functionally characterize the allele-specific effects of risk variants located in accessible regions of immune cell chromatin


    RESULTS: Of the 7 preferential variants, 5 exhibited allele-specific increases in nucleoprotein binding affinity and regulatory activity


    Conclusion: UBE2L3/YDJC UBE2L3/YDJC autoimmune risk haplotype increases UBE2L3 UBE2L3 expression by enhancing YY1 - mediated interaction between UBE2L3 UBE2L3 and YDJC YDJC promoter .


    Gopalakrishnan, J.


    , Tessneer, KL, Fu, Y.
    , Pasula, S.


    Gopalakrishnan, J.
    , Tessneer, KL, Fu, Y.
    , Pasula, S.
    , Pelikan, RC, Kelly, JA, Wiley, GB and Gaffney, PM (2022), Variants on the  UBE2L3 / YDJC  Autoimmune Disease Risk Haplotype Increase  UBE2L3  Expression by Modulating CCCTC-Binding Factor and YY1 Binding.
    Arthritis Rheumatol, 74: 163-173.
      UBE2L3 YDJC UBE2L3 https://doi.
    org/10.
    1002/art.
    41925 Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.